The 26th Annual Meeting of the SITC will include dynamic presentations, interactive panel discussions and scientific posters on the most timely topics in cancer immunotherapy. The event will also highlight vital information on clinical trial design and re November 3, 2011

The premiere industry event for rheumatolology, the American College of Rheumatology Annual Scientific Meeting focuses on new research related to the study and delivery of rheumatologic care or services. The event includes poster sessions, scientific abstract presentations, education based on practice gaps, and hands-on skill training sessions.

• Daniel Furst will present “Epidemiology of Systemic Sclerosis in a Large US Managed Care Population.”
• Rajesh Narwall will present “Population pharmacokinetics of sifalimumab, an investigational anti-interferon-a monoclonal antibody, in systemic lupus erythematosus patients.”
• Jon Hatcher will present “Blocking the granulocyte macrophage colony stimulating factor receptor alpha chain prevents mechanical hypersensitivity in a mouse model of inflammatory pain.”
• Kavita Gajria will present “A Systematic Review Of Patient-Reported Outcomes Rheumatoid Arthritis And Impact Of Regulatory Guidance.”
• Robert Georgantas will present “TNFa Contributes to Inclusion Body Myositis Muscle Wasting Through Suppression of Critical Myoblast Differentiation MicroRNA miR-1, 133, and 206.”
• Gerd Burmester will present “Mavrilimumab (an Anti-GM-CSFRα Monoclonal Antibody) in Subjects with Rheumatoid Arthritis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled Study.”
• Brandon Higgs will present “Systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients share activation of a common type I interferon pathway.”
• Kate Strand will present “Responsiveness Of Health Related Quality Of Life Measures In Rheumatoid Arthritis Randomized Controlled Trials.”